Get the latest Science News and Discoveries

Revolutionary mRNA Cancer Vaccine Shows Immense Promise in First-Ever Human Clinical Trial

In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine created at the University of Florida rapidly reprogrammed the immune system to target glioblastoma, the deadliest and most aggressive form of brain tumor. The results mirror those in 10 pet dog patients suffering

None

Get the Android app